8-bromo cyclic adenosine monophosphate and Cytomegalovirus

8-bromo cyclic adenosine monophosphate has been researched along with Cytomegalovirus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, H; Hamajima, K; Kudoh, I; Lu, Y; Okuda, K; Suzuki, M; Takahashi, T; Toda, S; Watabe, S; Xin, KQ1

Other Studies

1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Cytomegalovirus

ArticleYear
8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
    Gene therapy, 2000, Volume: 7, Issue:8

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Administration, Intranasal; Animals; Combined Modality Therapy; Cytomegalovirus; Dose-Response Relationship, Drug; Genetic Therapy; Genetic Vectors; HIV Envelope Protein gp160; Hypersensitivity, Delayed; Immunoglobulin G; Injections, Intramuscular; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Promoter Regions, Genetic; T-Lymphocytes, Cytotoxic; Vaccines, DNA

2000